查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2011163

互联医疗设备市场：2026-2032年全球市场预测（按产品类型、连接技术、最终用户、应用和分销管道划分）

Connected Medical Devices Market by Product Type, Connectivity Technology, End User, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，互联医疗设备市场价值将达到 672.6 亿美元，到 2026 年将成长至 822.3 亿美元，到 2032 年将达到 2,913.7 亿美元，复合年增长率为 23.29%。

主要市场统计数据
基准年 2025 672.6亿美元
预计年份：2026年 822.3亿美元
预测年份 2032 2913.7亿美元
复合年增长率 (%) 23.29%

从策略角度概述了整合感测、分析和连结如何改变临床工作流程、产品设计重点和市场进入动态。

透过整合感测、分析和连结功能，互联医疗设备正在重塑医疗服务模式，使临床监测超越传统医疗环境。硬体、软体和云端服务的整合正在建立新的诊疗路径，实现早期发现和早期疗育，并推广持续监测模式，从而缩短住院时间，改善慢性病管理。因此，医疗设备製造商、数位医疗公司和医疗服务提供者都必须将产品开发与临床工作流程、互通性标准和网路安全框架相协调。

软体成熟度的加速提升、连接标准的进步以及赎回模式的演变，正在重新定义竞争优势和监管义务。

互联医疗设备产业正经历一系列变革，这些变革正在重新定义竞争优势、监管预期和医疗服务模式。首先，内建软体和人工智慧驱动的分析技术的成熟度曲线正从原型阶段的实验转向临床可用的功能，促使製造商采用生命週期方法进行软体检验、上市后效能监测和演算法管治。因此，产品蓝图现在将临床证据的生成和可解释性纳入其中，不再只是可选功能，而是核心商业需求。

关税措施对互联医疗设备相关人员的采购、产品设计和供应链韧性的营运和策略影响。

近期针对医疗设备原料和成品的贸易措施，给製造商和供应商在成本、采购和进度安排方面带来了一系列复杂的压力。关税和报復性贸易措施的迭加，改变了零件和组件原产地认定的标准，迫使企业重新评估其供应商组合，增加库存缓衝，并加快近岸外包和双重采购策略的实施。这些调整对下游环节，例如前置作业时间、品管流程以及用于生产设备升级的资金配置，都产生了影响。

将产品子类别、临床应用、最终用户环境、连接方式和分销管道与推动采用的因素联繫起来进行详细的細項分析。

精细化的市场区隔揭示了产品设计、临床应用、终端用户环境、连接方式和分销策略如何影响产品的市场接受度和商业优先顺序。从产品类型（诊断设备、监测设备、手术设备、治疗设备和穿戴式装置）的角度进行分析，突显了临床医生和患者的细微需求。诊断设备，特别是成像系统、就地检验盒和超音波诊断设备，需要高诊断准确性、可靠的校准流程以及与影像存檔和通讯系统的互通性。监测设备，例如心电图监视器、血糖监视器和生命征象监视器，优先考虑持续的资料完整性、电源管理和警报管理，以支援临床决策。手术医疗设备，包括电外科设备、内视镜和机器人手术系统，需要严格的可靠性、与无菌环境的兼容性以及与手术室资讯系统的无缝整合。治疗医疗设备，例如透析系统、输液帮浦和人工呼吸器，则强调安全冗余、剂量准确性和故障安全机制。穿戴式设备，例如健身追踪器和智慧型手錶，在消费者易用性、感测器精度和无缝行动连线之间取得了良好的平衡，从而促进了持续使用。

影响美洲、欧洲、中东和非洲以及亚太市场商业化、监管策略和供应链选择的区域因素。

区域趋势对互联医疗设备的需求驱动因素、监管要求和市场推广执行有显着影响。在美洲，成熟的医保报销体系、先进的医院基础设施以及对远端监测的强劲需求，使得那些能够显着减少急症治疗需求的设备更受青睐。此外，该地区紧密的公立和私人保险公司网络，有望加速与慢性病管理和急性后期护理路径相契合的设备推广。同时，美洲的供应链物流结构以及与零件供应商的地理位置接近性，使其成为近岸外包和产品快速改进的中心。

对成熟新兴企业进行策略分析，重点关注平台化、伙伴关係和基于证据的商业化：旨在扩大连网型设备的交付范围

互联医疗设备领域的主要企业呈现一致的趋势：将软体和服务整合到核心产品中，优先考虑网路安全和法规遵从性，并建立生态系统伙伴关係以扩大临床应用范围。市场领导者正在投资模组化平台，以实现快速功能部署和第三方集成，同时保持严格的变更管理流程，用于软体更新和上市后监测。他们的研发方法也强调与临床机构的合作、与医疗系统进行试点部署以及迭代检验，以增强临床医生的信心并建立报销机制。

为製造商和供应商提供可操作的策略措施，以加强连网型设备产品开发、供应链韧性和上市时间模式。

产业领导企业应采取三管齐下的策略，将产品策略、营运韧性和市场参与相结合，从而从互联医疗设备中创造长期价值。首先，应在产品开发的早期阶段纳入监管和临床证据规划，以确保软体迭代、演算法更新和硬体改进在后续流程中尽可能顺畅。这种积极主动的规划能够缩短新功能的上市时间，并在获得结果数据后加强与支付方的沟通。

采用透明的研究途径，结合相关人员访谈、技术评估、监管审查和情境测试，以检验对连网型设备。

本分析所依据的综合研究，透过对关键相关人员的访谈、技术产品评估、政策和监管审查以及对二手文献的整合，全面展现了互联医疗设备的整体情况。与临床医生、采购负责人、监管专家和设备工程师的结构化访谈是主要资讯来源，这些访谈基于实际操作情况和证据需求，从而形成深刻见解。除这些对话外，还对具有代表性的设备架构、连接协定堆迭和网路安全状况进行了技术评估，以识别反覆出现的技术限制和整合模式。

全面阐述将互联医疗设备创新转化为可持续的临床价值和商业性成功的系统性要求。

互联医疗设备代表着医疗保健转型的重要前沿领域，它为早期诊断、慢性病持续管理以及更有效率地利用临床资源提供了途径。先进感测技术、内建软体和广泛互联的整合，对产品设计、证据产生和上市后管理提出了新的要求。能够将临床检验、网路安全和互通性与稳健的供应链相协调的企业，将更有利于扩大和维持其市场优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 互联医疗设备市场：依产品类型划分

  • 诊断设备
    • 医学影像系统
    • 即时检测套组
    • 超音波诊断设备
  • 监控设备
    • 心电图监测仪
    • 血糖监测仪
    • 生命征象监测
  • 手术器械
    • 电外科设备
    • 内视镜设备
    • 机器人手术系统
  • 治疗设备
    • 透析系统
    • 点滴帮浦
    • 人工呼吸器
  • 穿戴式装置
    • 健身追踪器
    • 智慧型手錶

第九章 互联医疗设备市场：依连接技术划分

  • Bluetooth
  • 细胞
  • NFC
  • Wi-Fi
  • Zigbee

第十章 互联医疗设备市场：依最终使用者划分

  • 门诊部
  • 诊所
  • 诊断中心
  • 居家照护环境
    • 老年护理
    • 术后护理
  • 医院
    • 私立医院
    • 公立医院

第十一章 互联医疗设备市场：依应用领域划分

  • 药物输送
    • 静脉输液
    • 吸入系统
    • 注射给药
  • 诊断影像
    • CT
    • MRI
    • 超音波影像
    • X射线
  • 病患监测
    • 门诊监测
    • 重症监护监测
    • 远端监控
  • 復原
    • 神经復健
    • 职业疗法
    • 物理治疗
  • 手术支援
    • 导航系统
    • 机器人支援
  • 远端医疗
    • 远距离诊断
    • 远端患者监护
    • 视讯咨询

第十二章 互联医疗设备市场：依分销管道划分

  • 离线
  • 在线的

第十三章 互联医疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 互联医疗设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 互联医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国互联医疗设备市场

第十七章：中国互联医疗设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Apple Inc.
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Dexcom Inc.
  • Fitbit Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Garmin Ltd.
  • GE Healthcare
  • Honeywell International Inc.
  • iHealth Labs Inc.
  • Insulet Corporation
  • Johnson & Johnson Services Inc.
  • Masimo Corporation
  • Medtronic plc
  • Omron Healthcare Inc.
  • Philips Healthcare
  • ResMed Inc.
  • Roche Diagnostics
  • Samsung Electronics Co. Ltd.
  • Siemens Healthineers AG
  • Smiths Medical
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
Product Code: MRR-43750BE226AB

The Connected Medical Devices Market was valued at USD 67.26 billion in 2025 and is projected to grow to USD 82.23 billion in 2026, with a CAGR of 23.29%, reaching USD 291.37 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 67.26 billion
Estimated Year [2026] USD 82.23 billion
Forecast Year [2032] USD 291.37 billion
CAGR (%) 23.29%

A strategic overview of how integrated sensing, analytics, and connectivity are transforming clinical workflows, product design priorities, and market entry dynamics

Connected medical devices are reshaping care delivery by integrating sensing, analytics, and connectivity to extend clinical oversight beyond traditional care settings. This convergence of hardware, software, and cloud-enabled services has cultivated new care pathways, enabled earlier detection and intervention, and fostered continuous monitoring models that reduce hospital stays and improve chronic disease management. The result is a landscape in which device manufacturers, digital health companies, and care providers must synchronize product development with clinical workflows, interoperability standards, and cybersecurity postures.

Across the ecosystem, innovation is no longer confined to component improvements; it now requires systems thinking that aligns user experience, regulatory compliance, and data lifecycle management. As the clinical and commercial value of connected devices increases, organizations must confront complex trade-offs: balancing device miniaturization and battery longevity against data fidelity; reconciling the pace of software feature releases with evidence generation; and harmonizing revenue models that mix device sales with recurring services. Effective responses demand cross-functional collaboration among engineering, clinical, regulatory, and commercial teams.

Stakeholders also operate within an evolving policy and trade environment that can influence sourcing, manufacturing, and distribution decisions. Taken together, these dynamics are creating both opportunity and risk: the capacity to deliver differentiated patient outcomes at scale, and the exposure to supply chain disruption, cyber threats, and reimbursement uncertainty. This introduction sets the stage for an integrated analysis that follows, revealing the strategic inflection points organizations must address to capture long-term value from connected medical devices.

How accelerated software maturity, advanced connectivity standards, and shifting reimbursement models are redefining competitive advantage and regulatory obligations

The connected medical device landscape is undergoing a series of transformative shifts that are redefining competitive advantage, regulatory expectations, and care delivery models. First, the maturity curve of embedded software and AI-driven analytics has moved from prototype experimentation to clinically actionable features, prompting manufacturers to adopt lifecycle approaches to software validation, post-market performance monitoring, and algorithm governance. Consequently, product roadmaps now integrate clinical evidence generation and explainability as core commercial requirements rather than optional capabilities.

Second, the proliferation of low-power wide-area networks and higher-throughput cellular standards is expanding the feasible envelope for remote monitoring and telehealth integration. This connectivity evolution is enabling devices to operate in distributed care models with lower latency, richer telemetry, and greater reliability than prior generations. It also elevates the importance of interoperability-both syntactic and semantic-so that patient data can be aggregated, normalized, and acted upon across disparate health IT systems.

Third, reimbursement and procurement practices are gradually adapting to value-based paradigms, creating incentives for devices that demonstrably reduce acute care utilization and improve chronic disease outcomes. In parallel, regulatory authorities are refining guidance on software as a medical device, cybersecurity risk management, and real-world performance evidence, compelling manufacturers to embed regulatory strategy into product development cycles.

Finally, market structure is shifting as strategic partnerships between device makers, cloud providers, and clinical networks proliferate. These alliances accelerate market access but also introduce new dependencies and shared liabilities. The net effect of these shifts is a competitive landscape where agility in clinical validation, connectivity integration, and post-market stewardship distinguishes market leaders from laggards.

Operational and strategic consequences of tariff measures on sourcing, product design, and supply chain resilience for connected medical device stakeholders

Recent trade measures targeting medical device inputs and finished goods have introduced a complex set of cost, sourcing, and scheduling pressures for manufacturers and suppliers. Tariff actions, coupled with reciprocal trade responses, have changed the calculus for where components and assemblies are produced, prompting firms to reassess supplier portfolios, increase inventory buffers, and accelerate nearshoring or dual-sourcing strategies. These adjustments have downstream effects on lead times, quality control processes, and capital allocation for manufacturing upgrades.

Operationally, increased duties on specific components raise the effective landed cost of devices and can compress margins unless offset by pricing adjustments, supplier cost reductions, or moves to alternative materials. In many cases, manufacturers facing tariff exposure have pursued redesigns that substitute tariffed parts with functionally equivalent alternatives sourced from different jurisdictions. Such redesigns often entail qualification testing and updated regulatory submissions, creating timelines that extend beyond immediate commercial cycles.

Strategic responses to the tariff environment are varied. Some organizations elect to consolidate higher-value assembly within tariff-favored jurisdictions, while others build in pricing elasticity through service contracts and managed care arrangements that shift part of the cost burden. At the same time, procurement teams emphasize contract language that preserves renegotiation rights in the face of tariff escalations and encourage longer-term supply agreements to secure capacity.

Importantly, tariffs also influence innovation pathways. When component costs rise, development priorities may pivot toward higher-margin devices, software-enabled service layers, or aftermarket consumables that are less exposed to cross-border duties. Meanwhile, policy uncertainty surrounding trade measures increases the value of scenario planning and stress-testing for product portfolios, ensuring firms can preserve operational continuity and market access under alternative tariff trajectories.

In-depth segmentation analysis linking product subclasses, clinical applications, end-user environments, connectivity modalities, and distribution channels to adoption levers

Granular segmentation reveals how product design, clinical application, end-user contexts, connectivity choices, and distribution strategies shape adoption dynamics and commercial priorities. When viewed through Product Type lenses such as Diagnostic Devices, Monitoring Devices, Surgical Devices, Therapeutic Devices, and Wearable Devices, the nuanced needs of clinicians and patients emerge. Diagnostic Devices-and specifically imaging systems, point-of-care test kits, and ultrasound devices-demand high diagnostic accuracy, robust calibration workflows, and interoperability with picture archiving and communication systems. Monitoring Devices such as ECG monitors, glucose monitors, and vital signs monitors prioritize continuous data integrity, power management, and alarm management to support clinical decision-making. Surgical Devices, including electrosurgical devices, endoscopic devices, and robotic surgery systems, require exacting reliability, sterile compatibility, and seamless integration with operating room informatics. Therapeutic Devices like dialysis systems, infusion pumps, and ventilators emphasize safety redundancies, dose delivery accuracy, and fail-safe mechanisms. Wearable Devices, represented by fitness trackers and smart watches, balance consumer ergonomics, sensor fidelity, and seamless mobile connectivity to encourage sustained engagement.

Application-based segmentation further clarifies value propositions across drug delivery, imaging, patient monitoring, rehabilitation, surgical assistance, and telehealth. Within drug delivery, distinctions among infusion drug delivery, inhalation systems, and injection drug delivery influence device form factor, adherence monitoring, and connectivity to electronic medication records. Imaging modalities such as CT, MRI, ultrasound imaging, and X-ray carry distinct regulatory pathways, capital intensity, and clinician training requirements. Patient monitoring spans ambulatory monitoring, critical care monitoring, and remote monitoring, each with different signal-capture priorities, latency tolerances, and integration needs with clinical workflows. Rehabilitation applications from neurorehabilitation to occupational therapy and physical therapy leverage sensors and feedback loops to quantify outcomes and support remote care. Surgical assistance via navigation systems and robotic assistance underscores the convergence of precision mechanics, real-time imaging, and surgeon interface design. Telehealth subsegments-remote diagnosis, remote patient monitoring, and video consultation-highlight the need for seamless, secure data exchange and clear escalation pathways.

End-user segmentation across ambulatory care centers, clinics, diagnostic centers, home care settings, and hospitals shapes procurement cycles and support requirements. Home care settings, which include elderly care and post-operative care, prioritize ease of use, caregiver support, and remote clinician oversight. Hospitals, whether private or public, demand scale, service-level agreements, and evidence of clinical and economic benefit to support capital investments. Connectivity Technology choices-Bluetooth (including BLE and Classic Bluetooth), cellular standards spanning 2G through 5G, NFC, Wi-Fi (802.11ac and 802.11n), and Zigbee-determine device interoperability, power consumption, range, and security architecture. Finally, Distribution Channel differentiation between offline and online pathways influences customer experience, installation services, and aftermarket support, with online channels accelerating initial procurement but offline channels often remaining critical for complex device installation and training.

Regional considerations that shape commercialization, regulatory strategy, and supply chain choices across the Americas, Europe Middle East Africa, and Asia Pacific markets

Regional dynamics materially influence demand drivers, regulatory requirements, and go-to-market execution for connected medical devices. In the Americas, mature reimbursement landscapes, advanced hospital infrastructure, and a strong appetite for remote monitoring combine to favor devices that demonstrate clear value in reducing acute care utilization. The region also features a dense network of private and public payers, which can accelerate adoption of devices that align with chronic disease management and post-acute care pathways. Meanwhile, supply chain logistics and proximity to component suppliers make the Americas a focal point for nearshoring and rapid product iterations.

Europe, Middle East & Africa present a heterogeneous environment where regulatory harmonization efforts coexist with divergent procurement models. In many European markets, centralized purchasing and health technology assessment processes require robust clinical and economic evidence, while Middle Eastern and African markets may present high-growth pockets driven by private hospital expansion and investment in digital health infrastructure. Across this region, data protection standards and interoperability initiatives influence device design and cloud architecture decisions, necessitating adaptable regulatory strategies and localized support models.

Asia-Pacific exhibits a broad spectrum of maturity, from advanced markets with strong domestic manufacturing ecosystems to rapidly developing healthcare systems that leapfrog legacy infrastructure through digital-first deployments. The region's scale and diversity create opportunities for scalable, lower-cost device variants and modular platforms that can be customized to local clinical needs. Additionally, the availability of contract manufacturers and electronics suppliers supports cost optimization strategies, while evolving reimbursement frameworks and large patient populations present fertile ground for remote monitoring and telehealth solutions. Taken together, regional insights underscore the need for differentiated commercialization strategies that align evidence generation, supply chain design, and partnership ecosystems to local market realities.

Analysis of incumbent and challenger company strategies highlighting platformization, partnerships, and evidence-driven commercialization to scale connected device offerings

Leading companies in the connected medical device arena demonstrate consistent patterns: integration of software and services into their core offerings, prioritization of cybersecurity and regulatory compliance, and cultivation of ecosystem partnerships to extend clinical reach. Market leaders invest in modular platforms that enable rapid feature deployment and third-party integrations, while maintaining rigorous change-management processes for software updates and post-market surveillance. Their R&D approaches emphasize clinical collaboration, pilot deployments with health systems, and iterative validation to build clinician trust and reimbursement pathways.

Smaller and mid-sized firms often compete by focusing on niche clinical problems, leveraging agility to iterate user interfaces and accelerate time-to-market. These organizations commonly pursue partnerships with cloud and analytics providers to supplement internal capabilities, and they target partnerships with channel distributors or health systems to secure initial scale. Many such firms adopt hybrid business models that combine device sales with recurring revenue from analytics subscriptions, remote monitoring services, or consumable components.

Across the competitive landscape, there is a growing trend of strategic alliances between traditional device manufacturers and digital health specialists. These collaborations accelerate access to data science capabilities, patient engagement tools, and population health platforms. At the same time, cross-industry entrants emphasize speed and experience design but must rapidly develop clinical validation processes and regulatory expertise to compete sustainably. Collectively, these company-level behaviors reveal a competitive imperative: integrate clinical evidence, robust cybersecurity, and partnership-driven distribution to scale effectively in complex care environments.

Practical strategic moves for manufacturers and providers to fortify product development, supply chain resilience, and go-to-market models for connected devices

Industry leaders should adopt a three-pronged approach that aligns product strategy, operational resilience, and market engagement to capture long-term value from connected medical devices. First, embed regulatory and clinical evidence planning at the earliest stages of product development so that software iterations, algorithm updates, and hardware revisions proceed with minimal downstream friction. Proactive planning reduces time to market for new capabilities and strengthens payor dialogues when outcomes data becomes available.

Second, redesign supply chain and sourcing strategies to increase resilience against trade disruptions and tariff-induced cost pressures. This includes diversifying component suppliers, qualifying alternate materials where feasible, and evaluating nearshoring for critical assemblies. Simultaneously, align procurement contracts to include flexibility clauses for tariff pass-throughs and establish strategic inventory buffers for key components that face volatile trade exposure.

Third, prioritize interoperability, cybersecurity, and user-centered design to accelerate adoption across care settings. Invest in open APIs, standards-based data models, and rigorous penetration testing, while conducting clinician-centered usability studies that minimize training burdens. In parallel, develop commercial models that blend capital equipment sales with subscription services, enabling predictable revenue while offering customers lower upfront costs.

Finally, cultivate strategic partnerships with payors, health systems, and technology providers to co-develop reimbursement pathways and integrated care programs. Use pilot deployments to gather real-world evidence that supports reimbursement negotiations and expands clinical indications. Executed together, these recommendations position organizations to reduce operational risk, enhance product-market fit, and convert connected device capabilities into durable commercial advantage.

Transparent research approach combining stakeholder interviews, technical assessments, regulatory reviews, and scenario testing to validate connected device insights

The research synthesis underpinning this analysis integrates primary stakeholder interviews, technical product assessments, policy and regulatory reviews, and secondary literature synthesis to produce a holistic view of the connected medical device landscape. Primary inputs included structured interviews with clinicians, procurement officers, regulatory specialists, and device engineers to ground insights in operational realities and evidence needs. These conversations were complemented by technical assessments of representative device architectures, connectivity stacks, and cybersecurity postures to surface recurring engineering constraints and integration patterns.

Regulatory and policy review processes examined current guidance on software as a medical device, cybersecurity requirements, and trade measures affecting medical technology supply chains. This review was paired with a comparative analysis of regional procurement mechanisms and reimbursement frameworks to assess how evidence thresholds and purchasing behaviors differ across markets. Secondary literature and public filings were analyzed to validate company strategies and to triangulate industry trends, while case studies of successful pilot deployments were used to illustrate pathways to scale.

Analytical methodologies combined qualitative thematic coding with scenario-based stress testing to evaluate sensitivity to tariff changes, connectivity shifts, and regulatory updates. Where applicable, evidence hierarchies were applied to weigh clinical studies, pilot outcomes, and real-world performance data. Throughout, transparency in assumptions and source provenance was maintained to enable reproducibility and to support client follow-up questions for deeper dives into specific product or regional nuances.

Concluding perspective on the systemic requirements for translating connected medical device innovation into durable clinical value and commercial success

Connected medical devices represent a pivotal frontier in healthcare transformation, offering pathways to earlier diagnosis, continuous chronic disease management, and more efficient use of clinical capacity. The confluence of advanced sensing, embedded software, and pervasive connectivity has created new expectations for product design, evidence generation, and post-market stewardship. Organizations that synchronize clinical validation, cybersecurity, and interoperability with resilient supply chains will be better positioned to scale and sustain market advantage.

Yet the path forward is complex. Tariff actions and trade uncertainty compel firms to reassess sourcing strategies and cost structures, while evolving regulatory and reimbursement landscapes require disciplined evidence planning. Market leaders are responding by platformizing offerings, forging strategic partnerships, and investing in real-world performance evidence that supports clinician adoption and payer coverage. Success will hinge on an integrated approach that aligns product development, operations, and go-to-market execution around measurable clinical and economic outcomes.

In closing, the institutions that treat connected devices as systems-where hardware, software, clinical workflows, and commercial models are co-designed-will unlock the greatest value. Those that apply rigorous risk management to supply chains and regulatory pathways, while maintaining a relentless focus on user needs and data quality, will convert technological promise into sustained clinical impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Connected Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Systems
    • 8.1.2. Point Of Care Test Kits
    • 8.1.3. Ultrasound Devices
  • 8.2. Monitoring Devices
    • 8.2.1. ECG Monitor
    • 8.2.2. Glucose Monitor
    • 8.2.3. Vital Signs Monitor
  • 8.3. Surgical Devices
    • 8.3.1. Electrosurgical Devices
    • 8.3.2. Endoscopic Devices
    • 8.3.3. Robotic Surgery Systems
  • 8.4. Therapeutic Devices
    • 8.4.1. Dialysis Systems
    • 8.4.2. Infusion Pumps
    • 8.4.3. Ventilators
  • 8.5. Wearable Devices
    • 8.5.1. Fitness Trackers
    • 8.5.2. Smart Watches

9. Connected Medical Devices Market, by Connectivity Technology

  • 9.1. Bluetooth
  • 9.2. Cellular
  • 9.3. NFC
  • 9.4. Wi Fi
  • 9.5. Zigbee

10. Connected Medical Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Clinics
  • 10.3. Diagnostic Centers
  • 10.4. Home Care Settings
    • 10.4.1. Elderly Care
    • 10.4.2. Post Operative Care
  • 10.5. Hospitals
    • 10.5.1. Private Hospitals
    • 10.5.2. Public Hospitals

11. Connected Medical Devices Market, by Application

  • 11.1. Drug Delivery
    • 11.1.1. Infusion Drug Delivery
    • 11.1.2. Inhalation Systems
    • 11.1.3. Injection Drug Delivery
  • 11.2. Imaging
    • 11.2.1. CT
    • 11.2.2. MRI
    • 11.2.3. Ultrasound Imaging
    • 11.2.4. X Ray
  • 11.3. Patient Monitoring
    • 11.3.1. Ambulatory Monitoring
    • 11.3.2. Critical Care Monitoring
    • 11.3.3. Remote Monitoring
  • 11.4. Rehabilitation
    • 11.4.1. Neurorehabilitation
    • 11.4.2. Occupational Therapy
    • 11.4.3. Physical Therapy
  • 11.5. Surgical Assistance
    • 11.5.1. Navigation Systems
    • 11.5.2. Robotic Assistance
  • 11.6. Telehealth
    • 11.6.1. Remote Diagnosis
    • 11.6.2. Remote Patient Monitoring
    • 11.6.3. Video Consultation

12. Connected Medical Devices Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Connected Medical Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Connected Medical Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Connected Medical Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Connected Medical Devices Market

17. China Connected Medical Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Apple Inc.
  • 18.7. Baxter International Inc.
  • 18.8. Becton Dickinson and Company
  • 18.9. Boston Scientific Corporation
  • 18.10. Dexcom Inc.
  • 18.11. Fitbit Inc.
  • 18.12. Fresenius Medical Care AG & Co. KGaA
  • 18.13. Garmin Ltd.
  • 18.14. GE Healthcare
  • 18.15. Honeywell International Inc.
  • 18.16. iHealth Labs Inc.
  • 18.17. Insulet Corporation
  • 18.18. Johnson & Johnson Services Inc.
  • 18.19. Masimo Corporation
  • 18.20. Medtronic plc
  • 18.21. Omron Healthcare Inc.
  • 18.22. Philips Healthcare
  • 18.23. ResMed Inc.
  • 18.24. Roche Diagnostics
  • 18.25. Samsung Electronics Co. Ltd.
  • 18.26. Siemens Healthineers AG
  • 18.27. Smiths Medical
  • 18.28. Stryker Corporation
  • 18.29. Zimmer Biomet Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONNECTED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ECG MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ENDOSCOPIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC SURGERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIALYSIS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY FITNESS TRACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SMART WATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NFC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NFC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NFC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WI FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WI FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY WI FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ZIGBEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ZIGBEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ZIGBEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELDERLY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELDERLY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ELDERLY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POST OPERATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POST OPERATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY POST OPERATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INFUSION DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INHALATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY INJECTION DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY X RAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY AMBULATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY CRITICAL CARE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NEUROREHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OCCUPATIONAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY VIDEO CONSULTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL CONNECTED MEDICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 208. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 211. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 213. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 214. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 215. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 216. AMERICAS CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 234. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 254. LATIN AMERICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY IMAGING, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY REHABILITATION, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL ASSISTANCE, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY TELEHEALTH, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPE CONNECTED MEDICAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST CONNECTED MEDICAL DEVICES MARKET SIZE, BY WEARABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST CONNE